
CAS 5593-20-4: Betamethasone dipropionate
Formula:C28H37FO7
InChI:InChI=1S/C28H37FO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1
InChI key:InChIKey=CIWBQSYVNNPZIQ-XYWKZLDCSA-N
SMILES:C(COC(CC)=O)(=O)[C@]1(OC(CC)=O)[C@]2(C)[C@@](C[C@@H]1C)([C@]3([C@](F)([C@@H](O)C2)[C@]4(C)C(CC3)=CC(=O)C=C4)[H])[H]
Synonyms:- (11-beta,16-beta)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione-17,21-dipropionate
- (11Beta,16Beta)-9-Fluoro-11-Hydroxy-16-Methyl-3,20-Dioxopregna-1,4-Diene-17,21-Diyl Dipropanoate
- (11β,16β)-9-Fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione
- (8Xi,9Xi,11Beta,14Xi,16Beta)-9-Fluoro-11-Hydroxy-16-Methyl-3,20-Dioxopregna-1,4-Diene-17,21-Diyl Dipropanoate
- (9Ξ,11Β,16Β)-17-[(Chloroacetyl)Oxy]-9-Fluoro-11-Hydroxy-16-Methyl-3,20-Dioxopregna-1,4-Dien-21-Yl Propanoate
- 1,4-Pregnadien-9-Alpha-Fluoro-16-Beta-Methyl-11-Beta, 17,21-Triol-3,20-Dione 17,21-Dipropionate
- 9--Fluoro-16--methyl-11,17,21-trihydroxy-1,4-pregnadiene-3,20-dione17,21-dipropionate
- 9-Fluoro-11Beta,17,21-Trihydroxy-16Beta-Methylpregna-1,4-Diene-3,20-Dione 17,21-Di(Propionate)
- 9A-Fluoro-16B-Methyl-11B,17A,21-Trihydroxy-1,4-Pregnadiene-3,20-Dione 17,21-Dipropionate
- 9Alpha-Fluoro-16Beta-Methyl-11Beta,17Alpha,21-Trihydroxy-1,4-Pregnadiene-3,20-Dione 17,21-Dipropionate
- Beta Methasone Dipropionate
- See more synonyms
Sort by
Betamethasone 17,21-dipropionate
CAS:Controlled ProductBetamethasone 17,21-dipropionate is a potent synthetic corticosteroid, which is derived from corticosteroids found naturally in the adrenal cortex. It functions primarily as an anti-inflammatory and immunosuppressive agent by modulating the expression of inflammatory mediators. Specifically, it binds to glucocorticoid receptors, altering gene transcription and inhibiting the migration of leukocytes to sites of inflammation. This results in reduced synthesis of inflammatory cytokines and decreased swelling, redness, and pain. The primary applications of Betamethasone 17,21-dipropionate are in the treatment of various dermatological conditions. It is frequently used to manage chronic inflammatory skin disorders such as psoriasis, eczema, and dermatitis. The compound's efficacy in reducing inflammation and itching makes it valuable in clinical settings for patients with persistent and/or severe symptoms. Scientists appreciate its ability to provide substantial symptomatic relief, although it is critical to consider the risk of potential side effects with prolonged usage. Its mechanism and established therapeutic benefits make Betamethasone 17,21-dipropionate a notable subject of study and application in dermatopharmacology.Formula:C28H37FO7Purity:Min. 95%Color and Shape:White PowderMolecular weight:504.59 g/molBetamethasone 17,21-Dipropionate
CAS:Formula:C28H37FO7Purity:>97.0%(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:504.60Betamethasone dipropionate, micronised, USP grade
CAS:Formula:C28H37FO7Purity:≤ 1.0%Color and Shape:White or almost white powderMolecular weight:504.59